Author

E. Lopez-Granados

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell-cell communication· 1 Assay:ChIP-seq· 1 Assay:CITE-seq· 1 Assay:DNA methylation· 1

Frequent Co-Authors

A. Arutyunyan· 1 shared A. Bertoletti· 1 shared A. Ortiz· 1 shared C. Berin· 1 shared C. Camara· 1 shared C. de la Calle-Fabregat· 1 shared C. Rodriguez-Gallego· 1 shared D. Lozano-Ojalvo· 1 shared

Activity by Year

2021-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Arutyunyan

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Single-Cell Atlas of Common Variable Immunodeficiency reveals germinal center-associated epigenetic dysregulation in B cell responses

J. Rodriguez-Ubreva, A. Arutyunyan, M. J. Bonder, L. Del Pino-Molina, S. Clark, C. de la Calle-Fabregat, L. Garcia-Alonso, L.-F. Handfield, L. Ciudad, E. Andres-Leon, F. Krueger, F. Catala-Moll, V. C. Rodriguez-Cortez, K. Polanski, L. Mamanova, , E. Ballestar

The paper creates a single-cell atlas of CVID, identifying epigenetic and transcriptional defects in memory B cells and linking them to impaired cell communication.

bioRxiv · Dec 20, 2021 · PreprintImmunology

Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naive and COVID-19 recovered individuals

C. Camara, D. Lozano-Ojalvo, E. Lopez-Granados, E. Paz-Artal, M. Pion, R. Correa-Rocha, A. Ortiz, M. Lopez-Hoyos, M. Erro Iribarren, J. Portoles, P. Portoles, M. Perez-Olmeda, J. Oteo-Iglesias, C. Berin, E. Guccione, , J. Ochando

This study examines how the second dose of the BNT162b2 vaccine affects T cell immunity in naive and previously infected individuals, finding reduced cellular immunity in recovered individuals.

bioRxiv · Mar 22, 2021Immunology